Nonalcoholic fatty liver disease (NAFLD) is a common chronic liver disease caused by over-nutrition. Impaired autophagy is closely related to NAFLD progression. Recently, ubiquitin-specific peptidase-10 (USP10) was reported to ameliorate hepatic steatosis, but the underlying mechanism is still unclear. In view of the potential effects of USP10 on autophagy, we investigated whether USP10 alleviated steatosis through autophagy.

HepG2 cells were treated with palmitic acid (PA) to model NAFLD in vitro. Lentivirus was used to regulate USP10 level in cells. Autophagic regulators were used to autophagic progression in cells. Western blotting, real-time fluorescence quantitative polymerase chain reaction, lipid drop staining and immunofluorescent staining were performed to determine the effect of USP10 on lipid autophagy. Student’s t-test and Tukey’s post hoc test were used to compare the means among groups.

PA induced cellular steatosis with dependance on autophagy. USP10 overexpression alleviated PA-induced steatosis, restored autophagic activity, promoted autophagic flux, including synthesis and degradation of autophagosomes, and lipid-targeted autophagy. In the presence of autophagy inhibitors, the protective effectiveness of USP10 on steatosis decreased. Furthermore, the specific inhibitor to C-jun N-terminal protein kinase-1 (JNK1), DB07268, abolished USP10-induced autophagy. However, during early stage inhibition of JNK1, compensatory expression of tuberous sclerosis complex-2 (TSC2) maintained autophagy. The degree of TSC2-to-JNK1 compensation was positively associated with USP10 level. Functionally, JNK1 and TSC2 were involved in the lipid-lowering effect of USP10.

USP10 alleviated hepatocellular steatosis in autophagy-dependent manner. JNK1/TSC2 signaling pathways were required for USP10-induced autophagy.

Liver stiffness (LS) measured by shear wave elastography (SWE) is often influenced by hepatic inflammation. The aim was to develop a dual-task convolutional neural network (DtCNN) model for the simultaneous staging of liver fibrosis and inflammation activity using 2D-SWE.

A total of 532 patients with chronic hepatitis B (CHB) were included to develop and validate the DtCNN model. An additional 180 consecutive patients between December 2019 and April 2021 were prospectively included for further validation. All patients underwent 2D-SWE examination and serum biomarker assessment. A DtCNN model containing two pathways for the staging of fibrosis and inflammation was used to improve the classification of significant fibrosis (≥F2), advanced fibrosis (≥F3) as well as cirrhosis (F4).

Both fibrosis and inflammation affected LS measurements by 2D-SWE. The proposed DtCNN performed the best among all the classification models for fibrosis stage [significant fibrosis AUC=0.89 (95% CI: 0.87–0.92), advanced fibrosis AUC=0.87 (95% CI: 0.84–0.90), liver cirrhosis AUC=0.85 (95% CI: 0.81–0.89)]. The DtCNN-based prediction of inflammation activity achieved AUCs of 0.82 (95% CI: 0.78–0.86) for grade ≥A1, 0.88 (95% CI: 0.85–0.90) grade ≥A2 and 0.78 (95% CI: 0.75–0.81) for grade ≥A3, which were significantly higher than the AUCs of the single-task groups. Similar findings were observed in the prospective study.

The proposed DtCNN improved diagnostic performance compared with existing fibrosis staging models by including inflammation in the model, which supports its potential clinical application.

Cardiac troponin T (cTnT) is independently associated with cardiovascular complications in patients with chronic kidney disease (CKD). The present study aimed to determine the factors related to cTnT levels in pre-dialysis CKD patients, which result in increased cardiovascular risk.

A total of 147 patients, with a mean age of 69.1 ± 14.7 years old, were enrolled. These participants were classified to estimated glomerular filtration rate (eGFR) and albuminuria categories, according to the Kidney Disease Improving Global Outcomes 2012 criteria. The estimated pulse wave velocity (ePWV), as an index of arterial stiffness, was calculated using an equation, which included age and mean blood pressure. Coronary arterial disease (CAD) and left ventricular hypertrophy (LVH) were also recorded. The cTnT concentrations were measured by high-sensitivity immunoassay. The significant correlation between cTnT and different variables was determined, and the significant risk factors for high cTnT levels were defined.

A significant correlation was observed between cTnT serum concentrations and age, triglycerides/HDL-C, ePWV, glucose, phosphate (P), intact-parathyroid hormone (i-PTH), serum uric acid and albuminuria, although the association with eGFR was shown to be significantly inverse. The multifactorial model revealed that current smoking (p = 0.03, OR = 8.3, 1.15–60.3), CAD (p = 0.001, OR = 25.2, 5.6–113.6), low eGFR (p = 0.001, OR = 0.9, 0.8–0.9), high ePWV (p = 0.04, OR = 2.6, 1.0–6.8), and primary renal disease (p = 0.001, OR = 3.8, 1.7–8.5) are independent risk factors for elevated cTnT levels, after adjusting for age, gender, obesity and albuminuria.

Arterial stiffness, smoking, primary renal disease and unregulated metabolic abnormalities may have an independent association between high cTnT levels and low eGFR in pre-dialysis CKD patients, with or without overt cardiovascular disease.

Natural killer (NK) cells are a gatekeeper of the body’s innate defense system against cancers and infections. A growing body of literature from us and others finds that NK cells promote anti-cancer immune surveillance, and that defects in NK cell development are associated with poor clinical prognosis of cancers. In preclinical studies, NK cells were found to drive tumor regression and delay tumor relapse. Because NK cells are potentially less damaging to the body and are easier to develop than T cell-based therapies, efforts are being made to improve NK cell cytotoxicity and in vivo persistence for use as an adoptive, off-the-shelf immunotherapy. In this review, we discuss how tumor-intrinsic and -extrinsic factors suppress NK cells in the cancer microenvironment. We also outline current strategies that restore NK surveillance in cancer and challenges facing the clinical use of NK cell-based therapies.

A considerable number of autoimmune hepatitis (AIH) patients completely or partially fail on first-line treatment. Several studies on the use of calcineurin inhibitors (CNIs) in the treatment of AIH have been published without focusing on indication. The aim was to assess the efficacy of CNIs in the treatment of adult AIH patients, specifically focusing on indication: first-line intolerant and with first-line insufficient response (failure to achieve or maintain remission), and with second versus third-line treatment.

A literature search included studies on the use of CNIs in adult AIH. Patients with past or present use of CNIs from the Dutch AIH group cohort were added. The primary endpoint was biochemical remission while using CNIs. Secondary endpoints were biochemical response, treatment failure, and adverse effects.

Twenty studies from the literature and nine Dutch patients were included describing the use of cyclosporine in 59 and tacrolimus in 219 adult AIH patients. The CNI remission rate was 53% in patients with insufficient response to first-line treatment and 67% in patients intolerant to first-line treatment. CNIs were used as second-line treatment in 73% with a remission rate of 52% and as third-line treatment in 22% with a remission rate of 26%. Cyclosporine was discontinued in 13% and tacrolimus in 11% of patients because of adverse events.

CNIs as rescue treatment in adult AIH patients are reasonably effective and safe both with insufficient response or intolerance to previous treatment. Prospective studies are needed.

Coagulation testing is essential for the diagnosis and management of a variety of hemophilia, thrombophilia, and complicated coagulopathies. This is often used prior to surgery, or as a follow-up investigation for patients being scrutinized for bleeding diathesis, or to monitor the anticoagulant therapy. When the results are abnormal, a mixing study is often the initial reflexive test that can provide valuable information to conclude the assessment, or help guide further investigations. If the mixing “corrects” the test results, a factor deficiency would be suspected. Otherwise, the presence of an inhibitor would be more likely. However, defining “correction” remains difficult and controversial. There are several available methods to determine whether a result is corrected. Each method has its own advantages and limitations. It is noteworthy that although a complete correction can be interpreted as factor deficiency, a partial or incomplete correction does not rule out the coexistence of factor deficiency and the presence of a coagulation inhibitor. Hence, caution should be taken in interpreting mixing study results for patients who are taking direct-acting oral anticoagulants. Ideally, mixing study results are interpreted in correlation with the patient’s clinical history, including bleeding or thrombosis history, and the use of anticoagulants. This review aimed to evaluate the methods used in interpreting coagulation mixing studies and to discuss their respective advantages and limitations

Polymerase chain reaction (PCR) techniques provide rapid detection of pathogens. This pilot study evaluated the diagnostic utility and clinical impact of multiplex real-time PCR (mRT-PCR, SeptiFast) vs. conventional microbial culture (CMC) in bile samples of patients with chronic cholestatic liver diseases (cCLDs), endoscopic retrograde cholangio-pancreatography (ERCP), and peri-interventional-antimicrobial-prophylaxis (pAP).

We prospectively collected bile samples from 26 patients for microbiological analysis by CMC and mRT-PCR. Concordance of the results of both methods was determined by Krippendorff's alpha (α) for inter-rater reliability and the Jaccard index of similarity.

mRT-PCRbile and CMCbile results were concordant for only Candida albicans (α=0.8406; Jaccard index=0.8181). mRT-PCRbile detected pathogens in 8/8 cases (100%), CMCbile in 7/8 (87.5%), and CMCblood in 5/8 (62.5%) with clinical signs of infection. mRT-PCRbile, CMCbile, and CMCblood had identical detection results in 3/8 (37.5%) with clinical signs of infection (two Klebsiella spp. and one Enterococcus faecium). The total pathogen count was significantly higher with mRT-PCRbile than with CMCbile (62 vs. 31; χ2=30.031, p<0.001). However, pathogens detected by mRT-PCRbile were more often susceptible to pAP according to the patient infection/colonization history (PI/CH) and surveillance data for antibiotic resistance in our clinic (DARC). Pathogens identified by mRT-PCRbile and resistant to pAP by PI/CH and DARC were likely to be clinically relevant.

mRT-PCR in conjunction with CMCs for bile analysis increased diagnostic sensitivity and may benefit infection management in patients with cholestatic diseases. Implementation of mRT-PCR in a bile sample-based diagnostic routine can support more rapid and targeted use of antimicrobial agents in cCLD-patients undergoing ERCP and reduce the rate/length of unnecessary administration of broad-spectrum antibiotics.

To date, the omentum-derived determinants of ovarian cancer (OC) metastasis to the omentum have not been well elucidated. We aimed to identify the pathogenesis, potential biomarkers, and prognostic indicators underlying the omental metastasis of OC.

The expression profile GSE120196 included datasets of omental tissues from four patients with benign gynecologic diseases and cancer-infiltrated omental tissues from ten patients with high-grade serous OC. Using this dataset, we performed an analysis of differentially expressed genes (DEGs), gene ontology, Kyoto Encyclopedia of Genes and Genome, and pathway networks. The most significant module based on protein-protein interaction (PPI) network was selected, and the genes in the module were identified as hub genes. Furthermore, survival analysis and translational level of hub genes were performed to verify the results.

A total of 301 upregulated DEGs and 128 downregulated DEGs were identified. Pathways in cancer, focal adhesion and Wnt signaling were found to play critical roles. Ten hub genes were identified from PPI network analysis. Expression levels of two key genes, COL1A1 and VCAN, were significantly associated with worse prognosis of patients with advanced ovarian cancer.

Our findings suggest that pathways in cancer, focal adhesion, Wnt signaling, and expression levels of two key genes, COL1A1 and VCAN, may become novel targets for the diagnosis and therapy of ovarian cancer with omental metastasis.

Uptake of breast cancer screening has been decreasing in England since 2007. However, the associated factors are unclear. On the other hand, survival among breast cancer patients have recently increased. We conducted a quasi-experimental analysis to test whether the trend-change in proportional incidence of non-screened cancers coincided with that in five-year net-survival.

We extracted population-based proportional incidence and age-standardized five-year net-survival data from Public Health England that included English women with invasive breast cancer diagnosed during 1995–2011 (linked to death certificates, followed through 2016). Piece-wise log-linear models with change-point/joinpoint were used to estimate temporal trends.

Among 254,063 women in England with invasive breast cancer diagnosed during 1995–2011, there was downward-to-upward trend-change in proportional incidence of non-screened breast cancers (annual percent change [APC]=5.6 after 2007 versus APC=−3.5 before 2007, p<0.001) in diagnosis-year 2007, when a steeper upward-trend in age-standardized five-year net survival started (APC=5.7 after 2007/2008 versus APC=0.3 before 2007/2008, p<0.001). Net-survival difference of screened versus non-screened cancers also significantly narrowed (18% in 2007/2008 versus 5% in 2011). Similar associations were found in all strata of race, cancer stage, grade, and histology, except in Black patients or patients with stage I, stage III, or grade I cancer.

There was a downward-to-upward trend-change in proportional incidence of non-screened breast cancers in 2007 that coincided with a steeper upward-trend in age-standardized five-year net survival among English women in 2007. Survival benefits of breast cancer screening decreased during 2007–2011. The data support reduction of breast cancer screening in some patients, but future validation studies are warranted.

The current World Health Organization classification of neuroendocrine neoplasms of the digestive system separates these tumors into two major categories: well-differentiated neuroendocrine tumors and poorly differentiated neuroendocrine carcinomas. These two groups are considered fundamentally different tumors, with different molecular abnormalities, prognoses, and treatment strategies. The cornerstone of the classification is proliferative rate of the tumor cells, as assessed by mitotic rate and Ki-67 labeling index. However, the range of mitotic rate and Ki-67 labeling index overlaps between high-grade, well-differentiated neuroendocrine tumor and poorly differentiated neuroendocrine carcinoma. In order to accurately separate these two entities, a systematic approach is necessary, which includes attention to the morphology, accurate assessment of the proliferative rate, review of any additional pathology materials, judicial use of immunohistochemistry, and correlation with clinical features. With this approach, the majority of tumors can be correctly classified as either high-grade, well-differentiated neuroendocrine tumor or poorly differentiated neuroendocrine carcinoma. This review aimed to evaluate the current World Health Organization classification system for neuroendocrine neoplasms of the digestive system, focusing on the differentiation between well-differentiated neuroendocrine tumors and poorly differentiated neuroendocrine carcinomas.

Alagille syndrome (AGS) is an autosomal dominant multisystem disorder caused by mutations in the JAG1 and NOTCH2 genes. AGS has been rarely reported in adult patients, mainly because its characteristics in adults are subtle. The study aimed to improve the understanding of adult AGS by a descriptive case series.

Eight adults diagnosed with AGS at our hospital between June 2016 and June 2019 were included in the study. Clinical data, biochemical results, imaging results, liver histopathology, and genetic testing were analyzed.

Three female and five male patients with a median age of 24.5 years at the time of diagnosis were included in the analysis. The clinical manifestations were adult-onset (62.5%, 5/8), cholestasis (50%, 4/8), butterfly vertebrae (62.5%, 5/8), systolic murmurs (12.5%, 1/8), typical facies (12.5%, 1/8), posterior embryotoxon, and renal abnormalities (0/8). Genetic sequencing showed that all patients had mutations, with four occurring in the JAG1 gene and four in the NOTCH2 gene. Six were substitution mutations, one was a deletion mutation, and one was a splicing mutation. Five had been previously reported; but the others, one JAG1 mutation and two NOTCH2 mutations were unique and are reported here for the first time.

The clinical manifestations highlighted by the current diagnostic criteria for most adults with AGS are atypical. Those who do not meet the criteria but are highly suspicious of having AGS need further evaluation, especially genetic testing.

Alanine aminotransferase (ALT) is a common clinical indicator of liver inflammation. The current Chinese guidelines for the management of chronic hepatitis B (CHB) recommend antiviral treatment for patients with detectable hepatitis B virus (HBV) DNA and persistent ALT levels (ALTs) exceeding the upper limit of normal. However, it has been recently reported that patients with chronic HBV infection, especially HBeAg-negative patients with persistently normal ALTs, may have liver biopsy findings of significant inflammation and fibrosis. For HBeAg-negative patients with chronic HBV infection and normal ALTs, many controversial questions have been asked. To treat or not? When to initiate the treatment? Which drug is appropriate? In this review, we summarize the available data on the management of HBeAg-negative patients with chronic HBV infection and normal ALTs with the aim of improving the current clinical management.

The recent histologic subtyping of lung adenocarcinoma has demonstrated the prognostic values of histologic patterns in this malignancy. However, the histological features of lung squamous cell carcinoma (SCC) are much less established. This short review discusses several promising histological prognostic markers for SCC, including tumor budding, tumor cell nesting, and the spreading of tumors through air spaces. Wherever appropriate, the biological significance of these morphological features was also discussed. The investigators consider that histological prognostic markers are highly valuable in understanding the cancer biology of SCC, and in guiding clinical treatment. However, larger clinical cohorts are needed to better establish the prognostic values of the aforementioned histological markers. The application of modern technologies, including machine-learning, would make the histological analysis accurate and reproducible.

Morphologic variants of well-differentiated pancreatic neuroendocrine tumors (PanNETs) are uncommon. These variants may mimic non-PanNETs, and when under recognized, it would lead to misdiagnosis by fine-needle aspiration (FNA) biopsy. The present report describes the unique cytomorphologic features and diagnostic clues of pigmented, pleomorphic, clear cell/lipid-rich and oncocytic variants of well-differentiated PanNETs. The differential diagnoses of each morphologic variant are also discussed. Ancillary immunohistochemical studies with appropriate markers are crucial in the diagnostic work-up. Raising the awareness of PanNET morphologic variants is essential for preventing diagnostic pitfalls, and rendering an accurate diagnosis during the FNA diagnostic work-up of pancreatic lesions.

Hridayarnava Rasa is traditionally used cardio tonic in Ayurveda. This drug was selected for the evaluation of stabilization of erythrocyte membrane (EM) in high-fat diet induced atherosclerosis via rabbit model.

A total of 24 male white New Zealand rabbits were randomly divided into 6 groups (n = 4 each). Rabbits in group 1 were fed a standard pellet diet, those in group II rabbits a high-fat diet (HFD), those in groups III, IV and V increasing doses of H. Rasa and an HFD, and those in group VI an HFD diet plus Atorvastatin.

There was a significant reduction in rabbit sodium/potassium adenosine triphosphatase (Na+/K+ ATPase) at 30 (58.51%), 60 (61.40%), and 90 (64.92%) days of an HFD diet compared to the control group. Upon treatment with H. Rasa, the activity of Na+/K+ ATPase in groups III, IV, and V increased at 30, 60 and 90 days, respectively, compared to HFD induced rabbits. The Na+ concentration also increased significantly in HFD-administered rabbits at 30, 60 and 90 days as compared to controls. Serum K+ concentration was reduced at days 30, 60 and 90 in the HFD group and was increased in group V as compared to the control group. These levels improved with H. Rasa treatment whereas the atorvastatin-treated group exhibited an improvement only between dose levels 2 and 3.

These results suggest that HFD diminishes EM stabilization in atherosclerosis whereas H. Rasa protects EM by maintaining the Na+/K+ ATPase activity through a Na+/K+ pump. In atherosclerosis, an HFD reduces EM stabilization after administration of H. Rasa, which maintains Na+/K+ ATPase activity through a Na+/K+ pump.

Hepatic ischemic reperfusion injury (IRI) occurring during surgery seriously affects patient prognosis. The specific mechanism of IRI has not been fully elucidated. The study aim was to explore the changes of inflammatory environment, and the relationship of the Th17/Treg cell ratio and FOXO1 expression in hepatic IRI.

Liver samples at different ischemic times were collected from patients and mice. The expression of inflammatory markers and FOXO1 in the liver was detected by western blotting and qPCR. Phenotypic changes of liver lymphocytes were analyzed by flow cytometry. The AKT/Stat3/FOXO1 pathway was verified by targeting AKT with GSK2141795. The role of FOXO1 in liver inflammation and changes in lymphocyte phenotype was confirmed by upregulating FOXO1 with resveratrol.

Prolonged ischemic time aggravates liver injury in both humans and mouse models of hepatic IRI. IR-stress caused Th17/Treg imbalance and FOXO1 down-regulation by activating the AKT/Stat3/FOXO1 signaling pathway. Upregulation of FOXO1 reversed the Th17/Treg cytokine imbalance and altered the inflammation environment in the liver.

Liver IRI induced Th17/Treg imbalance. Upregulation of FOXO1 reversed the imbalance and alleviated liver inflammation.

Rosemary (Rosmarinus officinalis L.) extract is widely used in food, cosmetic and pharmaceutical industries. This study centered on the optimization of ethanolic extraction of rosemary leaves and evaluated the bioactivity of the extract.

The optimized rosemary extract was analyzed using high-performance liquid chromatography. The antioxidant activity of the rosemary extract was measured using 2,2′-Azinobis-(3-ethylBenzoThiazoline-6-Sulfonic) acid, 2,2-DiPhenyl-1-Picryl-Hydrazyl-hydrate, and ferric reducing antioxidant power assays. The antibacterial activity of the rosemary extract was tested using the disk diffusion method. Toxicity was tested using mice. Nitrite production by RAW 264.7 cells was used to determine the anti-inflammatory activity of the rosemary extract. The construction and statistical analysis of the experimental design was done using NemrodW (LPRAI, version 2000) software.

Optimization studies of rosemary leaf extract for carnosic and rosmarinic acid yields revealed a significant interaction between extraction temperature and time. A mathematical model was established, showing that the optimal conditions for maximum yields of carnosic acid (86.28 mg/g DW) and rosmarinic acid (8.37 mg/g DW) were at 155°C and 120 minutes. Biochemical analysis confirmed the extract’s richness in phenolic compounds, with carnosic acid and rosmarinic acid being the most abundant. Antioxidant assays demonstrated the extract’s efficacy, with notable anti-radical activity surpassing the standard Trolox in the DPPH assay. Additionally, the extract exhibited significant antibacterial activity against various pathogens, suggesting its potential as a natural food preservative.

The research successfully identified optimal extraction parameters for carnosic and rosmarinic acids from rosemary leaves, contributing to their efficient utilization. The extract showed potent antioxidant and antibacterial activities, which are attributed to the high content of active phenolic compounds. Furthermore, the absence of acute toxicity in mice and anti-inflammatory effects in macrophage cells support rosemary leaf extract’s safety and therapeutic potential. These findings pave the way for the application of rosemary extract as a natural additive in food and pharmaceutical industries.

There is an unmet need for new biomarkers to improve diagnostics and prognostics in primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC). Inter-α-inhibitor heavy chain 4 (ITIH4) is an abundant, liver-produced protein, and its synthesis may be altered in liver diseases. We investigated whether ITIH4 plasma concentrations were affected in PBC and PSC patients.

We developed an immunoassay specific for ITIH4 and determined ITIH4 plasma concentrations in 66 PBC, 126 PSC, 92 autoimmune hepatitis (AIH), 67 chronic hepatitis C (CHC), 33 alcoholic hepatitis (AH) patients and 138 healthy controls (HCs). Hepatic ITIH4 expression was investigated by immunohistochemistry in PBC.

The mean plasma concentration of ITIH4 was almost doubled in PBC [409 µg/mL (95% CI: 388–431)] and 35% higher in PSC [308 µg/mL, (95% CI: 296–319)] compared with HCs [226 µg/mL (95% CI: 221–231); p<0.001]. In PBC patients, ITIH4 correlated with IgM (rho=0.49, p<0.001). Responders to ursodeoxycholic acid treatment (UDCA) had lower levels of ITIH4 than incomplete responders [395 µg/mL (95% CI: 364–425)] vs. 460 µg/mL (95% CI: 421–498); p=0.02]. Four weeks of UDCA treatment had no effect (p=0.19). Increased ITIH4 immunohistochemical staining was seen in a liver biopsy from a PBC patient. ITIH4 levels in AIH [224 µg/mL (95% CI: 208–241)] and HCs were similar (p=0.8). ITIH4 levels were lower in AH [199 µg/mL (95% CI: 175–223)] and CHC [202 µg/mL (192–212)] patients than in HCs (p<0.05).

The plasma concentration of ITIH4 was highly elevated in patients with PBC and PSC, suggesting that ITIH4 should be further investigated as a biomarker in cholestatic liver disease.

Although whole body vibration (WBV) has been used to reduce pain, some studies have indicated that WBV can cause low back pain (LBP). This study provides an overview of the current literature on the use of WBV to treat LBP and its effects on muscle strength, postural stability, and quality of life.

A literature research was conducted using the search terms “Whole Body Vibration” and “Low Back Pain” in the PubMed, PEDro, OVID, Cochrane Library, Web of Science, Google Scholar, and Scopus databases. All articles published up to November 2021 were included. Articles that did not have WBV as a treatment were excluded. The PEDro score was used to test methodological quality.

Of the 1,686 publications identified in the literature search, 21 studies focused on WBV as treatment for LBP, including 18 original studies, two reviews, and one meta-analysis. Ten of these 21 studies had good methodological quality. Five studies had a WBV duration of 12 weeks and were included in the meta-analysis (muscle strength, postural stability, and quality of life). Standardized mean differences and 95% confidence intervals were calculated. The effects range was from −0.86 to 0.84, favoring experimental groups.

Many positive effects of WBV on LBP were found. Given the effect sizes of the high-quality studies, it is reasonable to assume that WBV is effective for treating LBP.